ARCHIVES

Interview with Mark Ratain: Too Much Emphasis On Precision, Not Enough Emphasis On Accuracy In Dosing

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

Obituaries: Fritz Bach, 77, and William Wolff, 94

September 9, 2011

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990